Nicergoline is an ergot-derived medication acting as a selective alpha-1A adrenergic receptor antagonist, primarily used in the management of vascular disorders, cerebral thrombosis, and atherosclerosis… Read more
![Chemical structure of ((6aR,9R,10aS)-10a-methoxy-4-methyl-7-nitroso-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methyl 5-bromonicotinate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F57682-67-4-6aR9R10aS-10a-methoxy-4-methyl-7-nitroso-466a7891010a-octahydroindolo43-fgquinolin-9-ylmethyl-5-bromonicotinate.png&w=3840&q=75)
![Chemical structure of ((6aR,9R,10aS)-10a-methoxy-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6aR9R10aS-10a-methoxy-7-methyl-466a7891010a-octahydroindolo43-fgquinolin-9-ylmethanol.png&w=3840&q=75)








































Nicergoline is an ergot-derived medication acting as a selective alpha-1A adrenergic receptor antagonist, primarily used in the management of vascular disorders, cerebral thrombosis, and atherosclerosis to enhance cerebral blood flow. Laboratories utilize this collection of Nicergoline reference standards, impurities, and metabolites to facilitate rigorous analytical testing and quality control processes. This range includes pharmacopeial and non-pharmacopeial impurities—such as N-desmethyl derivatives, N-oxides, and various isomers—which are essential for accurate impurity profiling and verifying the safety and stability of the active pharmaceutical ingredient. Furthermore, stable isotope labelled compounds are available to serve as internal standards for precise quantification during method validation and bioanalytical studies. These materials support laboratories in maintaining compliance with regulatory requirements throughout the drug development and manufacturing lifecycle.